LIMN Liminatus Pharma Inc.: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik liminatuspharma.com (LIMN)

High R&D costs and strict FDA oversight create significant barriers for competitors. A team of leading immunologists is retained through stock options, ensuring workforce stability. The EV/Sales history demonstrates the market valuation of revenue excluding debt, where the 0.00 mark serves as a key metric. However, the absence of commercial sales makes the financial stability of Liminatus Pharma (LIMN) entirely dependent on new investments.

Nilai perusahaan marang pendapatan: Liminatus Pharma Inc. (LIMN) kanggo 23.11.2025 - 20.11.2026

liminatuspharma.com - rincian analitis lan metrik utama (LIMN)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Liminatus Pharma LIMN
Sampel barang Liminatus Pharma

This indicator reflects the total enterprise value relative to sales volume, excluding the impact of debt load to determine an objective market revaluation of the asset. By analyzing the EV/Sales valuation chart, an investor can identify overbought risks, which is critical for Liminatus Pharma (LIMN), whose capitalization relies on the potential of CAR-T therapy against solid tumors and the uniqueness of GCC antigen targeting.

Analisis pesaing Liminatus Pharma

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|compasstherapeutics.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Replimune Inc.|Lyell Immunopharma (LYEL) - Rasio nilai perusahaan marang pendapatan|Innate Pharma S.A. - Nilai bisnis marang pendapatan|PYXS (Pyxis) - Multiplikator EV/Sales|Multiplikator EV/Sales cgen.com|Rasio nilai perusahaan marang pendapatan IO Biotech (IOBT)|STRO: Nilai perusahaan marang volume dodolan|MiNK Therapeutics Inc. - Nilai perusahaan marang pendapatan|werewolftx.com (HOWL) - Multiplikator nilai perusahaan marang pendapatan|Immix Biopharma Inc. - Multiplikator EV/Sales|ALXO - Multiplikator EV/Sales|CUE: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PDSB|Rasio nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings|MAIA Biotechnology (MAIA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP